Ye Luxi, Zhou Lijun, Wang Shengping, Sun Lining, Wang Jiazhou, Liu Quan, Yang Xi, Chu Li, Zhang Xiaofei, Hu Weigang, Lin Jie, Zhu Zhengfei
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
J Cancer. 2021 Jan 18;12(6):1734-1741. doi: 10.7150/jca.51212. eCollection 2021.
Our previous work showed that para-aortic lymph node (PALN) metastasis was the major failure pattern in lower thoracic esophageal squamous cell carcinoma (LTESCC) patients who presented abdominal LN failure after curative surgery. We thereby aim to generate a computerized tomography (CT)-based documentation of PALNs and to propose a clinical target volume (CTV) for this region. Sixty-five patients were enrolled. The epicentre of each PALN was drawn onto an axial CT image of a standard patient with reference to the surrounding anatomical landmarks. A CTV for PALN was generated based on the final result of node distribution, and was evaluated for dosimetric performance in three simulated patients. All the studied 248 LNs were below the level of 1.0 cm above the celiac artery (CA), and 94.76% were above the bottom of vertebra L3. Horizontally, 93.33% of the LNs in the celiac level were located within an expansion of 1.5 cm on the CA, and 94.12% of the LNs in the superior mesenteric artery (SMA) level were within 1.5 cm on the left side of the SMA. Below the SMA, all the LNs were behind the left renal vein, left to the right border of the inferior vena cava, and 98.51% of the LNs were medial to the lateral surface of the left psoas major. The proposed CTV could cover 92.74% of the LNs and was dosimetrically feasible. The proposed CTV is the first one to focus on the high-risk area of abdominal failure in LTESCC patients after surgery and can serve as a reference in the adjuvant radiotherapy for LTESCC patients.
我们之前的研究表明,对于接受根治性手术后出现腹部淋巴结转移的下胸段食管鳞状细胞癌(LTESCC)患者,主动脉旁淋巴结(PALN)转移是主要的失败模式。因此,我们旨在生成基于计算机断层扫描(CT)的PALN记录,并为此区域提出临床靶体积(CTV)。纳入了65例患者。参照周围解剖标志,将每个PALN的中心绘制在标准患者的轴向CT图像上。基于淋巴结分布的最终结果生成PALN的CTV,并在三名模拟患者中评估其剂量学性能。所有研究的248个淋巴结均位于腹腔干(CA)上方1.0 cm水平以下,94.76%位于L3椎体底部上方。在水平方向上,腹腔干水平93.33%的淋巴结位于CA 1.5 cm范围内,肠系膜上动脉(SMA)水平94.12%的淋巴结位于SMA左侧1.5 cm范围内。在SMA以下,所有淋巴结均位于左肾静脉后方、下腔静脉右缘左侧,98.51%的淋巴结位于左腰大肌外侧表面内侧。所提出的CTV可覆盖92.74%的淋巴结,且在剂量学上是可行的。所提出的CTV是首个关注LTESCC患者术后腹部转移高危区域的CTV,可为LTESCC患者的辅助放疗提供参考。